BSX vs CORT · P/E 20, rev $10.65B vs P/E 199, rev $421.1M
Boston Scientific Corp (BSX) versus Corcept Therapeutics Incorporated (CORT) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported CORT revenue for 2026-06-30 was $421.1M. Net income was $11.2M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Not investment advice. Open the BSX and CORT stock pages for the full models.
Not investment advice.